# Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

> **NCT03532971** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 100 (actual)

## Conditions studied

- BK Virus Infection

## Interventions

- **OTHER:** Symptom index questionnaire
- **DIAGNOSTIC_TEST:** BK polyomavirus PCR
- **OTHER:** quality of life questionnaires

## Key facts

- **NCT ID:** NCT03532971
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-30
- **Primary completion:** 2020-09-14
- **Final completion:** 2020-09-14
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532971, "Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03532971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*